Search results
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 3 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Gateway - Quartz
Quartz· 5 days agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 6 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoThe vaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
Arcturus Therapeutics appoints Moncef Slaoui to board By Investing.com
Investing.com· 4 days ago(NASDAQ:ARCT), a biotechnology company specializing in mRNA medicines for infectious diseases and...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 7 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
UGA-developed nasal COVID-19 vaccine heading to clinical trials
WAGA fox local articles via Yahoo News· 4 days agoThe new vaccine was created by a team led by Biao He, a Fred C. Davidson...Tucker/UGA) "We are very...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 4 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...